<DOC>
	<DOCNO>NCT01773876</DOCNO>
	<brief_summary>Invasive Candida infection burden high mortality rate common intensive care unit . This study aim evaluate efficacy empirical treatment micafungin adult patient suspect invasive candidiasis .</brief_summary>
	<brief_title>Empirical Antifungal Treatment ICUS</brief_title>
	<detailed_description>Multicenter , randomize , double-blind parallel group compare adult patient suspect invasive candidiasis input 14-day empirical treatment micafungin ( MYCAMINE 100 mg ) placebo survival without invasive candidiasis 28 day initiation study treatment .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Age ≥ 18 year Persistent sepsis without documented invasive candidiasis : systemic inflammatory response syndrome ( SIRS ) presence two sign 4 [ temperature &lt; 36 ° C &gt; 38 ° C , heart rate &gt; 90/min , respiratory rate &gt; 20/min PaCO2 &lt; 32 mmHg , leukocytosis &gt; 12,000 / mm3 , &lt; 4.000/mm3 presence circulating immature form ( &gt; 10 % cell ) ] mechanical ventilation ( intubation tracheostomy ) 4 day ( 96 hour ) central line use broadspectrum antibacterial 4 calendar day ( 96 hour ) previous week presence least one extradigestive site colonize Candida sp . ( Urine , mouth , throat , upper low respiratory tract , skin fold , suction drain surgery ... ) , low digestive tract , take account positive sample rectal swabs / stool culture , absence proven bacterial infection untreated evidence invasive fungal infection ( positive blood culture , positive culture surgical site , deep biopsy fungal ) infection mold accord criterion group `` fungal infection EORTC '' organ failure Hospitalization intensive care 5 day ( 120 hour ) Giving free , informed writing . In absence person trust family member ( present ) consent emergency possible . Receiving social security system , Negative pregnancy test patient childbearing age Proven invasive fungal infection ( positive blood culture , positive culture surgical site , deep biopsy fungal infection ) , include aspergillosis require antifungal therapy time randomization Prognosis le 48 hour ( patient outcome fatal whatever treatment ) , Echinocandin antifungal treatment one day another antifungal 72 hour week inclusion visit , Allergy , hypersensitivity know intolerance echinocandins antifungal excipients drug Neutropenia ( ANC &lt; 500/mm3 ) History organ bone marrow , Recent chemotherapy ( le 6 month ) Systemic immunosuppressive therapy progress , corticosteroid dose 2 mg / kg / day prednisolone equivalent Participation another interventional study ICU stay make treatment evaluate within 28 day prior randomization Any clinical investigator deem incompatible conduct study acceptable security condition Pregnant lactate woman , Adults subject legal protection measure Persons deprive liberty judicial administrative decision , hospitalize without consent , person admit health facility social purpose research</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>survival without proven invasive candidiasis</keyword>
	<keyword>effectiveness</keyword>
	<keyword>micafungin versus placebo</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>tolerance</keyword>
</DOC>